rs8049607

This is a regulatory region variant variant in the LITAF gene.

GWAS Catalog Trait Associations (1)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

QT interval

Bihlmeyer NA et al. ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. Circulation. Genomic and Precision Medicine 11(1):e001758 (2018)
Allele T
OR 1.05
p 8.0e-44
N 95,626
Large GWAS
multi-ancestry
van Duijvenboden S et al. Genetic Basis and Prognostic Value of Exercise QT Dynamics. Circulation. Genomic and Precision Medicine 13(4):e002774 (2020)
Allele T
OR 0.04
p 8.0e-14
N 52,861
Large GWAS
European
Allele T
OR 1.25
p 6.0e-15
N 15,842
Large GWAS
European
Newton-Cheh C et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nature Genetics 41(4):399-406 (2009)
Allele T
OR 1.23
p 5.0e-15
N 13,685
Large GWAS
European

About LITAF

Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]

View all LITAF variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…